Travere Therapeutics Q3 Adj. EPS $(0.31) Misses $(0.06) Estimate, Sales $224.563M Beat $195.292M Estimate

Benzinga · 1d ago
Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.06) by 416.67 percent. This is a 152.54 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $224.563 million which beat the analyst consensus estimate of $195.292 million by 14.99 percent. This is a 36.22 percent increase over sales of $164.859 million the same period last year.